Lc. Flowers et al., Genetic changes during the multistage pathogenesis of human papillomaviruspositive and negative vulvar carcinomas, J SOC GYN I, 6(4), 1999, pp. 213-221
Citations number
34
Categorie Soggetti
Reproductive Medicine
Journal title
JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION
OBJECTIVE: To identify the molecular alterations found in 30 human papillom
avirus (HPV) positive (n = 15) and negative (n = 15) vulvar carcinomas (VC)
and their associated preinvasive lesions (VIN [vulvar intraepithelial neop
lasia]) and normal epithelium to determine a common molecular pathogenesis
of HPV positive and negative VC.
METHODS: Loss of heterozygosity (LOH) at seven 3p chromosomal regions (3p12
, 3p14.2, 3p14.3- 3p21.3, 3p22-24, 3p24.3, 3p25), 13q14 (RB) and 17p13.1 (p
53) loci, and TP53 gene mutations in microdissected archival tissues were i
nvestigated.
RESULTS: Fourteen of fifteen HPV positive VC had HPV 16 DNA sequences. The
fractional regional loss index (FRL), an index of total allelic loss at all
chromosomal regions analyzed, was greater in the HPV negative VCs than in
the HPV positive tumors (FRL = 0.55 versus 0.32; P = .048) and was also gre
ater in the HPV negative high-grade VINs as compared with the HPV positive
lesions (0.29 versus 0.02; P = .002). Overall, LOH at any 3p region was fre
quent (80%) in both groups of cancers and in their associated VIN lesions.
Although TP53 gene, mutations were present in a minority of VCs (20%), alle
lic losses at the TP53 locus were frequently present, especially in HPV neg
ative VCs, as compared with the HPV positive tumors (62% versus 15%; P = .0
2).
CONCLUSION: A greater number of molecular alterations are found in HPV nega
tive VCs compared with HPV positive tumors. Allelic losses at 3p are common
early events in vulvar carcinogenesis in HPV negative cancers detected at
a high rate in the corresponding high-grade precursor lesions (VIN II/III).
TP53 gene mutations with associated 17p13.1 LOH are more common in HPV neg
ative cancers. Copyright (C) 1999 by the Society for Gynecologic Investigat
ion.